Assessment of PENG Block as a Part of Multimodal Analgesia Following Hip Surgeries.

NCT06916000 · tracked via the Priya Life Science Egypt tracker

Sponsor

Ain Shams University

Phase

Not applicable

Started

2024-06-27

Last updated

2025-04-08

Condition(s) studied

Anesthesia

Investigational drug(s) / intervention(s)

Pericapsular nerve group (PENG) blockPatients will receive only other multimodal analgesics including LCFN block via 10 ml of 0.25% bupivacaine.

Pericapsular nerve group (PENG) block: As a part of multimodal analgesia patients will receive 20 ml of 0.25% bupivcacaine according to the technique described by Giron-Arango. All patients will receive the same analgesic protocol, which included IV paracetamol 1000 mg BID and NSAIDs if no contra-indication; PO celecoxib 100 mg BID. Also if needed nalbuphine 5 mg IV will be given as bolus demand dose and when the NRS pain score was equal to or greater than 4 points.

Patients will receive only other multimodal analgesics including LCFN block via 10 ml of 0.25% bupivacaine.: Patients will receive only other multimodal analgesics including LCFN block via 10 ml of 0.25% bupivacaine.

Study summary

to study the effect of Pericapsular nerve group (PENG) block as a part of multimodal analgesia regimen for hip arthroplasties

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion criteria: * Age group: 18 years and older. * ASA classification I to III. * BMI : 18-35 . * Gender: both sex Exclusion criteria: * Patient refusal. * Patients on long-term pain medications. * History of allergic reactions to local anesthetics * Patients who had mental illness or uncooperative patients. * BMI \> 35 . * Patients having coagulopathies or on anticoagulant or antiplatelet therapy. * Severe cardiopulmonary disease * ASA IV or more * Diabetic or other neuropathies

Primary outcome measure(s)

Pain score: pain assessment using a Numeric Rating System (NRS) immediately in the postoperative period. — 24 hours
Pain score: pain intensity will be evaluated using a Numeric Rating System (NRS) immediately in the postoperative period, every 2 hours during the first 6 hours and then every 6 hours till 24 hours postoperatively. Scores ranging from 0 to 10, with 0 indicating the absence of pain and 10 indicating the worst possible pain.

Trial sites (1)

Facility	City	Region	Status
Faculty of medicine, Ain Shams University	Abbasia	Cairo Governorate

More Ain Shams University trials in Egypt

A Study Of Moderately Hypo-Fractionated External-beam Radiotherapy With Concurrent Chemotherapy and High Dose Rate Brachytherapy In Cervical Cancer Recruiting

TCD and ONSD for Noninvasive Assessment of Increased ICP in TBI Active, not recruiting

Effect of Tributyrin Supplementation on Glycemic Control, Inflammation, and Cardiovascular Risk in Patients With Type 2 Diabetes Starting soon

This Study Aims to Evaluate the Safety and Efficacy of Fiber Supplementation on Constipation in Neurologically Impaired Children Using Rectal Wall Thickness Measurement by Ultrasound. Active, not recruiting

Patient Satisfaction and Crestal Bone Changes Around One-piece Zirconia(Zr) and Titanium(Ti) in Implant-Retained Mandibular Overdenture Recruiting

Other trials for the same condition

Effect of Total Intravenous Anesthesia vs Inhalational Anesthesia on the Level of Inflammatory Markers Active, not recruiting

Low-Thoracic Epidural Anesthesia For Laparoscopic Nephrectomy. Recruiting

The Effect of Opioid Free Anesthesia Using Ultrasound-Guided Bilateral Transversus Abdominus Plane Block and Dexmedetomidine Infusion Starting soon

Enhancing Renal Graft Function During Donor Anesthesia Recruiting

Continuous Spinal Anesthesia in Renal Transplantation Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06916000 on ClinicalTrials.gov ↗ ← All trials in Egypt